VANCOUVER, BC – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, will be participating… Read More
Recognition Reinforces Commitment to Creating an Exceptional People Experience TORONTO, ON – Takeda Canada Inc. (“Takeda”) announced that, for the second consecutive year, it has received Top Employer® certification for… Read More
Dr. Qi Wei, PhD, joins Frontage Laboratories Inc as Vice President, Global Genomic Services. Dr. Wei reports directly to Dr. John Lin, PhD, President Global Laboratory Services and will be… Read More
About MedTech Innovator MedTech Innovator is the largest and highest performing accelerator of medical technology in the world and the medtech industry’s premiere showcase and competition for innovative medical device,… Read More
Reset Mind Sciences Ltd. has received a shipment of PEX010, Filament’s botanical psilocybin drug candidate VANCOUVER, BC – Filament Health Corp. (OTCQB:FLHLF) (Cboe CA:FH) (FSE:7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic… Read More
